Channel Medsystems
Ric Cote has a diverse work experience in the healthcare industry. Ric began their career at Influence Medical as the Director of Sales and Marketing, where they successfully grew revenues from zero to over $2 million per month. The company was later acquired by American Medical Systems. Ric then worked as the CEO at Collagenesis, Inc. from 2000 to 2001. Ric joined American Medical Systems in 2003 as the Director of GYN Sales. In 2004, Ric became the Executive Vice President of Global Sales and Business Development at Conceptus, where they played a key role in increasing revenues from $4 million to over $140 million. Ric continued to excel in their career and joined Channel Medsystems in 2012 as the President and CEO. Additionally, they served on the Board of Directors at Channel Medsystems. Ric Cote also had experience as an Independent Consultant in 2012. Overall, Ric's experience highlights their leadership skills, expertise in sales and business development, and their ability to drive revenue growth in the healthcare industry.
Ric Cote earned their Bachelor of Applied Science (BASc) degree in Business Administration and Management, General from California State University-Sacramento. Ric attended the university from 1985 to 1990.
Channel Medsystems
Channel Medsystems is a medical device company dedicated to empowering every woman to take control of her health journey and live her best life. With a commitment to deliver innovative technologies that exceed the expectations of women and their gynecologists, Channel strives to develop easy-to-use, safe, and cost-effective medical devices, resulting in exceptional outcomes and superior patient comfort that are accessible to all women. Led by chief executive officer Ric Cote, Channel Medsystems has a seasoned executive leadership team with a track record of commercializing innovative medical devices. The company’s technology, Cerene® Cryotherapy, is a well-tolerated in-office endometrial ablation treatment that safely and effectively reduces heavy menstrual bleeding without general anesthesia and while preserving access to the uterine cavity for future diagnostic evaluations. Please review safety info (https://bit.ly/3qgfAtS) for additional information.